Free Trial

Allspring Global Investments Holdings LLC Boosts Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Prestige Consumer Healthcare logo with Medical background

Allspring Global Investments Holdings LLC boosted its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 19.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,575,170 shares of the company's stock after purchasing an additional 255,045 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 3.18% of Prestige Consumer Healthcare worth $113,570,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its holdings in shares of Prestige Consumer Healthcare by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 5,756,138 shares of the company's stock worth $352,391,000 after purchasing an additional 63,375 shares during the last quarter. Quadrature Capital Ltd bought a new position in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $320,000. Congress Wealth Management LLC DE grew its holdings in shares of Prestige Consumer Healthcare by 8.8% in the first quarter. Congress Wealth Management LLC DE now owns 124,281 shares of the company's stock valued at $9,018,000 after purchasing an additional 10,061 shares in the last quarter. Norden Group LLC increased its position in Prestige Consumer Healthcare by 1,593.7% in the first quarter. Norden Group LLC now owns 118,968 shares of the company's stock worth $8,632,000 after purchasing an additional 111,944 shares during the last quarter. Finally, First Trust Direct Indexing L.P. raised its stake in Prestige Consumer Healthcare by 18.5% during the first quarter. First Trust Direct Indexing L.P. now owns 4,422 shares of the company's stock valued at $321,000 after purchasing an additional 689 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Trading Down 1.7 %

NYSE:PBH traded down $1.24 during mid-day trading on Monday, hitting $71.31. 246,545 shares of the stock traded hands, compared to its average volume of 246,897. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. Prestige Consumer Healthcare Inc. has a 52 week low of $56.61 and a 52 week high of $75.80. The stock has a market capitalization of $3.54 billion, a price-to-earnings ratio of 17.10, a PEG ratio of 1.98 and a beta of 0.47. The firm's 50 day moving average is $71.47 and its two-hundred day moving average is $69.29.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, August 8th. The company reported $0.90 EPS for the quarter, beating analysts' consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.55% and a net margin of 18.43%. The firm had revenue of $267.10 million for the quarter, compared to analysts' expectations of $260.54 million. During the same quarter in the prior year, the firm posted $1.06 earnings per share. The company's quarterly revenue was down 4.4% on a year-over-year basis. On average, equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.43 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Jefferies Financial Group reissued a "hold" rating and issued a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson boosted their price objective on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a "buy" rating in a research note on Wednesday, August 28th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $94.20.

Check Out Our Latest Stock Analysis on Prestige Consumer Healthcare

About Prestige Consumer Healthcare

(Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

See Also

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Should you invest $1,000 in Prestige Consumer Healthcare right now?

Before you consider Prestige Consumer Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prestige Consumer Healthcare wasn't on the list.

While Prestige Consumer Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines